Original version

BBC One Oxfordshire

Panorama

Documentaries

Factual

News

Investigative documentary series revealing the truth about the stories that matter.

BBC News Channel

The BBC West region started on 1st September 1957 as part of the BBC Television Service, before becoming BBC One West.

BBC One West

The BBC South West region started on 20th April 1961 as part of the BBC Television Service, before becoming BBC One South West.

BBC One South West

The BBC South region started on 5th January 1961 as part of the BBC Television Service, before becoming BBC One South.

BBC One South

BBC One London

London

BBC One West Midlands

BBC One region covering Derbyshire, Leicestershire and Nottinghamshire.

BBC One East Midlands

The BBC East region started on 1st May 1959 as part of the BBC Television Service, before becoming BBC One East.

BBC One East

BBC One North West

The BBC North East & Cumbria region started in 1959 (tbc) as part of the BBC Television Service, before becoming BBC One North East & Cumbria.

BBC One North East & Cumbria

BBC One Yorkshire

Formerly part of a wider BBC One South East region that included London and part of the South region. Separated from BBC One London 2001-09-03 following reorganisation of the South East region.

BBC One South East

BBC One Cambridgeshire

BBC One Channel Islands

BBC One Yorks & Lincs

BBC One Scotland

Scotland

BBC Northern Ireland region started on 19th April 1955 as part of the BBC Television Service, before becoming BBC One Northern Ireland.

BBC One Northern Ireland

BBC One Wales

Wales

Started as BBC News 24 in 29/11/1997 and then became the BBC News Channel on 21/04/2008

Jeremy Vine

Angie Mason

Shelley Jofre

Panorama: A Risk Worth Taking?

A Risk Worth Taking?

06/09/2010

BBC One - Panorama, A Risk Worth Taking?

Shelley Jofre investigates the rise and fall of the drug Avandia.

Shelley Jofre investigates the drug Avandia and asks whether the medicine's regulator is putting the interests of the drugs industry before patients.

We're in the grip of a diabetes epidemic. The NHS spent more than half a billion pounds on medication for it in 2009. Patients trust that these drugs are safe, but does one come with a hidden cost to health? Shelley Jofre investigates the rise and fall of Avandia, until recently one of the UK's best-selling diabetes drugs, and asks whether the medicine's regulator is putting the interests of the drugs industry before patients.

Accessibility links

Programme Index

Panorama

A Risk Worth Taking?

Contributors

Genres

Brand

BBC One Oxfordshire

About BBC One